Kyverna Therapeutics fair value
None of the figures this calculator works from (earnings, free cash flow, revenue, book value, dividends) is positive for Kyverna Therapeutics today, so there is nothing to project yet.
Peers
Biological Products, (No Diagnostic Substances) · Pick stocks to compare with KYTX
Held by ETFs
KYTX is in 14 US ETFs. The largest of them, with KYTX's weight in each:
iShares Biotechnology ETFIBB0.02%of the fund
Fidelity Enhanced Small Cap ETFFESM0.01%of the fund
State Street SPDR S&P Kensho New Economies Composite ETFKOMP0.06%of the fund
Avantis U.S. Small Cap Equity ETFAVSC0.02%of the fund
iShares Micro-Cap ETFIWC0.06%of the fund
Vanguard Russell 2000 Value Index FundVTWV0.02%of the fund
Spot a number that looks wrong? Check it in KYTX's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing KYTX
Create a free account and get 14 days of Premium: every stock and every tool.
- Unlimited stocks
- Stock screener
- Portfolio tracker
- Editable DCF
- Compare side by side
- Unlimited alerts
No card. Moves to Free after, unless you upgrade.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.